Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults
A Registry-Based Study
Information & Authors
Information
Published In
Copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publication History
Received: November 6, 2020
Accepted: March 15, 2021
Published online: May 5, 2021
Published in issue: June 15, 2021
Disclosure
B.L. is affiliated with Baxter Healthcare Corp. None of the other authors declare any conflict of interest pertinent to the present work. Go to Neurology.org/N for full disclosures.
Study Funding
Supported by the Swedish Research Council (2019-01059). H.X. is supported by a postdoctoral grant from Strategic Research program in Neuroscience at Karolinska Institutet.
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Predicting rapid kidney function decline in middle-aged and elderly Chinese adults using machine learning techniques, BMC Medical Informatics and Decision Making, 25, 1, (2025).https://doi.org/10.1186/s12911-025-03043-2
- Heterogeneous treatment effects of GLP‐1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real‐world target trial emulation, Alzheimer's & Dementia, 21, 6, (2025).https://doi.org/10.1002/alz.70313
- Uremic Toxins, CKD, and Cognitive Dysfunction, Journal of the American Society of Nephrology, 36, 6, (1208-1226), (2025).https://doi.org/10.1681/ASN.0000000675
- Generalized framework for identifying meaningful heterogenous treatment effects in observational studies: A parametric data-adaptive G-computation approach, Statistical Methods in Medical Research, 34, 4, (648-662), (2025).https://doi.org/10.1177/09622802251316969
- Long-Term Physical Exercise for Preventing CKD in Older Adults, Journal of the American Society of Nephrology, (2025).https://doi.org/10.1681/ASN.0000000636
- Association of body weight and serum uric acid with Alzheimer's disease biomarkers and cognitive impairment, Journal of Alzheimer’s Disease, 104, 1, (255-268), (2025).https://doi.org/10.1177/13872877251315011
- Quantifying Cognitive Function in Diabetes: Relationships Between AD8 Scores, HbA1c Levels, and Other Diabetic Comorbidities, Biomedicines, 13, 2, (340), (2025).https://doi.org/10.3390/biomedicines13020340
- The effect of creatinine level on amyloid-β and tau plasma concentrations in a cohort of Alzheimer’s disease patients without kidney disease, Behavioural Brain Research, 477, (115289), (2025).https://doi.org/10.1016/j.bbr.2024.115289
- Kidney replacement therapies in the older person: challenges to decide the best option, Clinical Kidney Journal, (2025).https://doi.org/10.1093/ckj/sfaf020
- Low preoperative estimated glomerular filtration rate level is a risk factor for postoperative cognitive dysfunction in elderly undergoing elective total hip replacement: a prospective observational study, Psychogeriatrics, 25, 1, (2025).https://doi.org/10.1111/psyg.13238
- See more
Loading...
View Options
View options
PDF and All Supplements
Download PDF and Supplementary MaterialShort Form
Short FormFull Text HTML
View Full Text HTMLLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.
We thank Dr. Fischereder for the comments on our study.1 Our goal was to explore the association between kidney function and the risk of dementia, not to imply causation. While underlying mechanisms remain unclear, they do not preclude our findings from being plausible. Subsequent studies confirm an association between cognitive impairment and markers of kidney dysfunction.2,3 Experimental evidence suggests that uremia-induced chronic inflammation, oxidative stress, hypercoagulation, vitamin-D deficiency, klotho deficiency, hyperparathyroidism, anemia, and impaired peripheral amyloid-β clearance may lead to dementia.4 Besides, chronic kidney disease (CKD) may be a risk mediator for other conditions that cause dementia, such as smoking, hypertension, diabetes, and lipid disorders.4 It is important to note that our study reported similar associations in persons with and without diabetes or hypertension.
The hypothesis regarding dementia risk in individuals with high glomerular filtration rate (GFR) is interesting, but impossible to dissect from our report. Individuals with high GFR may be persons with glomerular hyperfiltration, or with an illness that results in low muscle mass. Our findings cannot inform on dementia risks for kidney donors, though the procedure is not thought to have adverse long-term health effects, including on kidney function. Carefully conducted studies with 10-years of follow-up show a consistent rise in GFR during the first few years after kidney donation, followed by a GFR decline that appears slower than the GFR decline in controls.5 Regardless of whether kidney dysfunction is the cause or mediator, our research highlights a population likely to benefit from dementia screening.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References
This registry-based analysis reports a strong correlation between renal function, estimated from a creatinine-based formula, and dementia.1 However, the pathological mechanism underlying this observation remains unclear. As direct effects of creatinine on cognitive function are highly unlikely, further discussion is needed to determine if causes or consequences of declining renal function are responsible for this association. In the case of reduced estimated glomerular filtration rate (eGFR) after living kidney donation from otherwise healthy individuals, such a differentiation is urgently needed. In later stages of chronic kidney disease, accumulation of unspecified uremic toxins may be one potential explanation—however, such a mechanism must be questioned at eGFR between 60 and 89 ml/min present in a large proportion of healthy individuals.
On the other hand, microvascular renal disease from Diabetes mellitus, smoking, or tobacco abuse accounts for approximately 50% of advanced chronic kidney disease. Among other comorbidities, diabetes mellitus, hypertension, and tobacco abuse are also significantly more prevalent with decreasing eGFR in this cohort. As outlined in the analysis of eGFR-decline, progressive renal injury is additionally associated with increasing risk for dementia. Another indicator towards a common cause for dementia and renal impairment is the increasing risk of dementia in individuals with eGFR > 105 ml/min, which may be found in diabetes mellitus. While the authors adjust their analyses for the above comorbidities statistically, it would be interesting to see a subgroup analysis evaluating if dementia is more prevalent in individuals who are free from Diabetes mellitus, hypertension, or tobacco abuse. Due to a potential increased risk for dementia, the ethical justification of living kidney donation should be questioned.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References